Holen Sie sich die Stockscreener-App
2.22
1.37%
0.03
Handel nachbörslich:
2.18
-0.04
-1.80%
Schlusskurs vom Vortag:
$2.19
Offen:
$2.26
24-Stunden-Volumen:
32,804
Relative Volume:
0.02
Marktkapitalisierung:
$5.26M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-11.28M
KGV:
-0.7375
EPS:
-3.01
Netto-Cashflow:
$-9.78M
1W Leistung:
+0.91%
1M Leistung:
-27.21%
6M Leistung:
-70.03%
1J Leistung:
-74.70%
1-Tages-Spanne:
$2.16
$2.28
1-Wochen-Bereich:
$2.13
$2.40
52-Wochen-Spanne:
$1.62
$14.67
Ensysce Biosciences Inc Stock (ENSC) Company Profile
Firmenname
Ensysce Biosciences Inc
Sektor
Branche
Telefon
(858) 263-4196
Adresse
7946 IVANHOE AVENUE, LA JOLLA
Vergleichen Sie ENSC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ENSC
Ensysce Biosciences Inc
|
2.22 | 5.22M | 0 | -11.28M | -9.78M | -3.01 |
|
ONC
Beone Medicines Ltd Adr
|
245.58 | 26.10B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
442.05 | 111.96B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.35 | 42.96M | 0 | 0 | 0 | 0.00 |
|
VRNA
Verona Pharma Plc Adr
|
81.20 | 6.39B | 0 | -153.72M | -103.81M | -2.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
490.28 | 63.52B | 14.09B | 4.50B | 2.96B | 39.28 |
Ensysce Biosciences Inc Aktie (ENSC) Neueste Nachrichten
Ensysce Biosciences (NASDAQ:ENSC) Raised to Hold at Wall Street Zen - Defense World
When (ENSC) Moves Investors should Listen - news.stocktradersdaily.com
Where are the Opportunities in (ENSC) - news.stocktradersdaily.com
Zacks Small Cap Analysts Boost Earnings Estimates for ENSC - Defense World
Ensysce Biosciences Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Ensysce Biosciences Advances in Pain Relief Innovation - TipRanks
Revolutionary Opioid Treatment Proves Overdose-Proof in Clinical Trials, Secures Key Patent - Stock Titan
Ensysce Biosciences Bolsters Management Team with Regulatory Expert - Stock Titan
Head-To-Head Contrast: CV Sciences (OTCMKTS:CVSI) and Ensysce Biosciences (NASDAQ:ENSC) - Defense World
(ENSC) Trading Signals - news.stocktradersdaily.com
Ensysce Biosciences (ENSC) to Release Earnings on Friday - Defense World
Press Release Distribution & PR Platform - ACCESS Newswire
Ensysce Biosciences to Present at the H.C. Wainwright 25th Annual Global Investment Conference - ACCESS Newswire
Ensysce Biosciences, Inc. Announces Closing of $3.0 Million Registered Direct Offering Priced at-the-Market Under NASDAQ Rules - ACCESS Newswire
Ensysce Biosciences Inc (ENSC) Clearly Signals Buy-Into the Stock: Don’t ignore the signals - Sete News
Ensysce Biosciences Secures $2.2M Funding Boost: Key Details on TAAP/MPAR Program Advancement - Stock Titan
Ensysce Biosciences Stock Price, Quotes and Forecasts | NASDAQ:ENSC - Benzinga
Ensysce Biosciences announces exercise of warrants for $2.2M gross proceeds - MSN
For Array Technologies Inc [ARRY], Analyst sees a rise to $7. What next? - dbtnews.com
Ensysce Biosciences (ENSC) Stock Surges on Patent News - GuruFocus
Ensysce Biosciences (ENSC) Secures $2.2 Million Through Warrant Exercise - GuruFocus
Ensysce Biosciences to raise $2.2 million through warrant exercise By Investing.com - Investing.com Canada
Ensysce Biosciences secures patent for OUD treatment By Investing.com - Investing.com South Africa
Ensysce Biosciences Stock Doubles In One Trading SessionHere's Why - AOL.com
Ensysce Biosciences to raise $2.2 million through warrant exercise - Investing.com Australia
Ensysce Biosciences Inc’s Shares Reel: -58.79% Quarterly Revenue Decline Amid 5.62M Market Cap - investchronicle.com
Dropbox Inc: Weathering Stock Market Storms with 7.92B Market Cap - investchronicle.com
Nuvation Bio Inc Inc. (NUVB) Price Performance: A Technical Analysis Perspective - investchronicle.com
Ensysce Biosciences Raises Fresh $2.2M Capital: H.C. Wainwright Backs Strategic Warrant Deal - Stock Titan
Sabre Corp (SABR) Stock: From Low to High in 52 Weeks - investchronicle.com
Analysts Are Recommending Ensysce Biosciences Inc (ENSC) As A Buy Candidate - Marketing Sentinel
Ensysce Biosciences Inc (NASDAQ:ENSC) stock: You might be surprised - uspostnews.com
Amentum Holdings Inc (AMTM) Shares Are Down -4.43% YTD - Marketing Sentinel
Crude Oil Falls Over 3%; Philip Morris Earnings Top Views - Benzinga
The Psychology of Altria Group Inc Inc. (MO) Price Performance: Understanding Market Sentiment - investchronicle.com
Ensysce (ENSC) Stock Sees Market Uplift Following New Patent Approval - Stocks Telegraph
The Psychology of Metsera Inc Inc. (MTSR) Price Performance: Understanding Market Sentiment - investchronicle.com
(ENSC) Technical Data - news.stocktradersdaily.com
Safety Shot Inc Inc. (SHOT) Price Performance: A Technical Analysis Perspective - investchronicle.com
Ensysce (ENSC) Advances PF614-MPAR in Overdose Protection Trial - GuruFocus
Dow Jumps Over 1,000 Points; Tesla Shares Rise After Q1 Results - Benzinga
Trump's Trade Hints Spark US Equity Gains - Finimize
Ensysce Biosciences secures patent for OUD treatment - Investing.com
Ensysce Biosciences Gets US Patent for Opioid Use Disorder Treatment; Shares Rise Pre-Bell - marketscreener.com
AtlasClear Holdings Inc (ATCH) Stock: A Year of Stock Market Dynamics - investchronicle.com
Revolutionary Opioid Treatment Patent Promises Safer Alternative to Methadone: Key Advantages Revealed - Stock Titan
An In-Depth Look At TPG Inc (TPG) - Marketing Sentinel
DVS’s Stock Market Pendulum: Swinging Between Gains and Losses - investchronicle.com
Ensysce Biosciences files to sell 652,439 shares of common stock for holders - MSN
ENSC stock touches 52-week low at $1.7 amid market challenges By Investing.com - Investing.com South Africa
ENSC stock touches 52-week low at $1.7 amid market challenges - Investing.com Australia
Finanzdaten der Ensysce Biosciences Inc-Aktie (ENSC)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.89%
3.74%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):